Coronary microvascular dysfunction induced by primary hyperparathyroidism is restored after parathyroidectomy

Circulation

Volumn 126, Issue 9, 2012, Pages 1031-1039

  Osto, Elena ^a,b   Fallo, Francesco ^a   Pelizzo, Maria Rosa ^a   Maddalozzo, Anna ^a   Sorgato, Nadia ^a   Corbetti, Francesco ^a   Montisci, Roberta ^c   Famoso, Giulia ^a   Bellu, Roberto ^a   Lüscher, Thomas F ^b   Iliceto, Sabino ^a   Tona, Francesco ^a,c  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Coronary flow reserve; Hyperparathyroidism; Microvascular dysfunction; Parathyroid hormone; Risk factors

Indexed keywords

CALCIUM; PARATHYROID HORMONE;

ADULT; AGE; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROSIS; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY FLOW RESERVE; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART RATE; HEMODYNAMIC MONITORING; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; MICROVASCULARIZATION; MULTIDETECTOR COMPUTED TOMOGRAPHY; PARATHYROIDECTOMY; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL;

ADENOMA; AGED; COMORBIDITY; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; DYSLIPIDEMIAS; ECHOCARDIOGRAPHY; FEMALE; HEMODYNAMICS; HUMANS; HYPERPARATHYROIDISM, PRIMARY; MALE; MICROCIRCULATION; MIDDLE AGED; MODELS, CARDIOVASCULAR; PARATHYROID HORMONE; PARATHYROID NEOPLASMS; PARATHYROIDECTOMY; RECOVERY OF FUNCTION;

EID: 84865481882     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.111.081307     Document Type: Article

References (47)

1. Andersson P, Rydberg E, Willenheimer R Primary hyperparathyroidism and heart disease: a review. Eur Heart J 2004;25:1776-1787. (Pubitemid 39330228)
2. Silverberg SJ, Shane E, Jacobs TP, Siris E, Bilezikian JP A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med. 1999;341:1249-1255. (Pubitemid 29489739)
3. Khan AA, Bilezikian JP, Potts JT Jr. The diagnosis and management of asymptomatic primary hyperparathyroidism revisited. J Clin Endocrinol Metab. 2009;94:333-334.
4. Almqvist EG, Bondeson AG, Bondeson L, Nissborg A, Smedgard P, Svensson SE Cardiac dysfunction in mild primary hyperparathyroidism assessed by radionuclide angiography and echocardiography before and after parathyroidectomy. Surgery. 2002;132:1126-1132. (Pubitemid 36026965)
5. Hagstrom E, Hellman P, Larsson TE, Ingelsson E, Berglund L, Sundstrom J, Melhus H, Held C, Lind L, Michaelsson K, Arnlov J Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation. 2009;119:2765-2771.
6. Rubin MR, Bilezikian JP, McMahon DJ, Jacobs T, Shane E, Siris E, Udesky J, Silverberg SJ The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years. J Clin Endocrinol Metab. 2008;93:3462-3470.
7. Anderson JL, Vanwoerkom RC, Horne BD, Bair TL, May HT, Lappe DL, Muhlestein JB Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors? Am Heart J 2011;162:331-339.e2.
8. Nickols GA Increased cyclic amp in cultured vascular smooth muscle cells and relaxation of aortic strips by parathyroid hormone. Eur J Pharmacol. 1985;116:137-144. (Pubitemid 16226367)
9. Rashid G, Bernheim J, Green J, Benchetrit S Parathyroid hormone stimulates the endothelial nitric oxide synthase through protein kinase A and C pathways. Nephrol Dial Transplant. 2007;22:2831-2837. (Pubitemid 350093420)
10. Hagstrom E, Ingelsson E, Sundstrom J, Hellman P, Larsson TE, Berglund L, Melhus H, Held C, Michaelsson K, Lind L, Arnlov J Plasma parathyroid hormone and risk of congestive heart failure in the community. Eur J Heart Fail. 2010;12:1186-1192.
11. Kosch M, Hausberg M, Vormbrock K, Kisters K, Gabriels G, Rahn KH, Barenbrock M Impaired flow-mediated vasodilation of the brachial artery in patients with primary hyperparathyroidism improves after parathyroidectomy. Cardiovasc Res. 2000;47:813-818.
12. Virdis A, Cetani F, Giannarelli C, Banti C, Ghiadoni L, Ambrogini E, Carrara D, Pinchera A, Taddei S, Bernini G, Marcocci C The sulfaphenazole- sensitive pathway acts as a compensatory mechanism for impaired nitric oxide availability in patients with primary hyperparathyroidism: effect of surgical treatment. J Clin Endocrinol Metab. 2010;95: 920-927.
13. Rubin MR, Maurer MS, McMahon DJ, Bilezikian JP, Silverberg SJ Arterial stiffness in mild primary hyperparathyroidism. J Clin Endocrinol Metab. 2005;90:3326-3330. (Pubitemid 41014293)
14. Schillaci G, Pucci G, Pirro M, Monacelli M, Scarponi AM, Manfredelli MR, Rondelli F, Avenia N, Mannarino E Large-artery stiffness: a reversible marker of cardiovascular risk in primary hyperparathyroidism. Atherosclerosis. 2011;218:96-101.
15. Caiati C, Montaldo C, Zedda N, Bina A, Iliceto S New noninvasive method for coronary flow reserve assessment: contrast-enhanced transthoracic second harmonic echo Doppler. Circulation. 1999;99:771-778. (Pubitemid 29083017)
16. Rubinshtein R, Yang EH, Rihal CS, Prasad A, Lennon RJ, Best PJ, Lerman LO, Lerman A Coronary microcirculatory vasodilator function in relation to risk factors among patients without obstructive coronary disease and low to intermediate Framingham score. Eur Heart J 2010; 31:936-942.
17. Peiris AN, Youssef D, Grant WB Secondary hyperparathyroidism: benign bystander or culpable contributor to adverse health outcomes? South Med J 2012;105:36-42.
18. Massry SG, Smogorzewski M The effects of serum calcium and parathyroid hormone and the interaction between them on blood pressure in normal subjects and in patients with chronic kidney failure. J Ren Nutr. 2005;15:173-177. (Pubitemid 40093704)
19. Resnick LM, Laragh JH, Sealey JE, Alderman MH Divalent cations in essential hypertension: relations between serum ionized calcium, magnesium, and plasma renin activity. N Engl J Med. 1983;309:888-891. (Pubitemid 13014029)
20. Rossi E, Sani C, Perazzoli F, Casoli MC, Negro A, Dotti C Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas. Am J Hypertens. 1995;8:884-893.
21. Shane E, Mancini D, Aaronson K, Silverberg SJ, Seibel MJ, Addesso V, McMahon DJ Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure. Am J Med. 1997;103:197-207. (Pubitemid 27413402)
22. Rutledge MR, Farah V, Adeboye AA, Seawell MR, Bhattacharya SK, Weber KT Parathyroid hormone, a crucial mediator of pathologic cardiac remodeling in aldosteronism [published online ahead of print February 29, 2012]. Cardiovasc Drugs Ther. doi:10.1007/s10557-012-6378-0.
23. Zittermann A, Fischer J, Schleithoff SS, Tenderich G, Fuchs U, Koerfer R Patients with congestive heart failure and healthy controls differ in vitamin D-associated lifestyle factors. Int J Vitam Nutr Res. 2007;77: 280-288. (Pubitemid 350114349)
24. Pilz S, Tomaschitz A, Drechsler C, Ritz E, Boehm BO, Grammer TB, Marz W Parathyroid hormone level is associated with mortality and cardiovascular events in patients undergoing coronary angiography. Eur Heart J 2010;31:1591-1598.
25. Grandi NC, Breitling LP, Hahmann H, Wusten B, Marz W, Rothenbacher D, Brenner H Serum parathyroid hormone and risk of adverse outcomes in patients with stable coronary heart disease. Heart. 2011;97:1215-1221.
26. Kamalov G, Ahokas RA, Zhao W, Shahbaz AU, Bhattacharya SK, Sun Y, Gerling IC, Weber KT Temporal responses to intrinsically coupled calcium and zinc dyshomeostasis in cardiac myocytes and mitochondria during aldosteronism. Am J Physiol Heart Circ Physiol. 2010;298: H385-H394.
27. Tomaschitz A, Ritz E, Pieske B, Fahrleitner-Pammer A, Kienreich K, Horina JH, Drechsler C, Marz W, Ofner M, Pieber TR, Pilz S Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease. Cardiovasc Res. 2012;94:10-19.
28. Isales CM, Barrett PQ, Brines M, Bollag W, Rasmussen H Parathyroid hormone modulates angiotensin ii-induced aldosterone secretion from the adrenal glomerulosa cell. Endocrinology. 1991;129:489-495.
29. Schiffrin EL Effects of aldosterone on the vasculature. Hypertension. 2006;47:312-318. (Pubitemid 43740260)
30. Vidal A, Sun Y, Bhattacharya SK, Ahokas RA, Gerling IC, Weber KT Calcium paradox of aldosteronism and the role of the parathyroid glands. Am J Physiol Heart Circ Physiol. 2006;290:H286-H294.
31. Brunaud L, Germain A, Zarnegar R, Rancier M, Alrasheedi S, Caillard C, Ayav A, Weryha G, Mirallie E, Bresler L Serum aldosterone is correlated positively to parathyroid hormone (PTH) levels in patients with primary hyperparathyroidism. Surgery. 2009;146:1035-1041.
32. Kalinowski L, Dobrucki LW, Malinski T Nitric oxide as a second messenger in parathyroid hormone-related protein signaling. J Endocrinol. 2001;170:433-440. (Pubitemid 32771444)
33. Roman RJ, Maier KG, Sun CW, Harder DR, Alonso-Galicia M Renal and cardiovascular actions of 20-hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids. Clin Exp Pharmacol Physiol. 2000;27: 855-865.
34. Rashid G, Bernheim J, Green J, Benchetrit S Parathyroid hormone stimulates endothelial expression of atherosclerotic parameters through protein kinase pathways. Am J Physiol Renal Physiol. 2007;292: F1215-F1218. (Pubitemid 46572440)
35. Tanaka M, Tokunaga K, Maruyama T, Otagiri M, Tominaga Y, Itoh K, Matsushita K, Komaba H, Fukagawa M Parathyroidectomy markedly reduces oxidative stress in a patient with primary hyperparathyroidism. Ther Apher Dial. 2011;15(suppl 1):38-41.
36. Vita JA Endothelial function. Circulation. 2011;124:e906-e912.
37. Vaziri ND, Ni Z, Wang XQ, Oveisi F, Zhou XJ Downregulation of nitric oxide synthase in chronic renal insufficiency: role of excess PTH Am J Physiol. 1998;274:F642-649.
38. Throckmorton D, Kurscheid-Reich D, Rosales OR, Rodriguez-Commes J, Lopez R, Sumpio B, Zhong Q, Ding KH, McCarthy R, Barrett PQ, Isales CM Parathyroid hormone effects on signaling pathways in endothelial cells vary with peptide concentration. Peptides. 2002;23:79-85. (Pubitemid 34113766)
39. Yan SF, Harja E, Andrassy M, Fujita T, Schmidt AM Protein kinase C beta/early growth response-1 pathway: a key player in ischemia, atherosclerosis, and restenosis. J Am Coll Cardiol. 2006;48:A47-A55. (Pubitemid 44648643)
40. Pinton P, Rimessi A, Marchi S, Orsini F, Migliaccio E, Giorgio M, Contursi C, Minucci S, Mantovani F, Wieckowski MR, Del Sal G, Pelicci PG, Rizzuto R Protein kinase C beta and prolyl isomerase 1 regulate mitochondrial effects of the life-span determinant p66shc. Science. 2007; 315:659-663. (Pubitemid 46214712)
41. Nechama M, Uchida T, Mor Yosef-Levi I, Silver J, Naveh-Many T The peptidyl-prolyl isomerase Pin1 determines parathyroid hormone mRNA levels and stability in rat models of secondary hyperparathyroidism. J Clin Invest. 2009;119:3102-3114.
42. Chiasson VL, Munshi N, Chatterjee P, Young KJ, Mitchell BM Pin1 deficiency causes endothelial dysfunction and hypertension. Hypertension. 2011;58:431-438.
43. Isales CM, Sumpio B, Bollag RJ, Zhong Q, Ding KH, Du W, Rodriguez-Commes J, Lopez R, Rosales OR, Gasalla-Herraiz J, McCarthy R, Barrett PQ Functional parathyroid hormone receptors are present in an umbilical vein endothelial cell line. Am J Physiol Endocrinol Metab. 2000;279: E654-E662.
44. Nickols GA, Metz MA, Cline WH Jr. Endothelium-independent linkage of parathyroid hormone receptors of rat vascular tissue with increased adenosine 3+,5-monophosphate and relaxation of vascular smooth muscle. Endocrinology. 1986;119:349-356. (Pubitemid 16100747)
45. Buus NH, Bottcher M, Hermansen F, Sander M, Nielsen TT, Mulvany MJ Influence of nitric oxide synthase and adrenergic inhibition on adenosine-induced myocardial hyperemia. Circulation. 2001;104:2305-2310. (Pubitemid 33049513)
46. Marini C, Giusti M, Armonino R, Ghigliotti G, Bezante G, Vera L, Morbelli S, Pomposelli E, Massollo M, Gandolfo P, Minuto F, Sambuceti G Reduced coronary flow reserve in patients with primary hyperparathyroidism: a study by G-SPECT myocardial perfusion imaging. Eur J Nucl Med Mol Imaging. 2010;37:2256-2263.
47. Maniero C, Fassina A, Seccia TM, Toniato A, Iacobone M, Plebani M, De Caro R, Calo LA, Pessina AC, Rossi GP Mild hyperparathyroidism: a novel surgically correctable feature of primary aldosteronism. J Hypertens. 2012;30:390-395.